CROI 2023 Research Highlights for GBMSM

As people with prostates (PwP) get older, they are more likely to have prostatic conditions such as BPH, prostatitis, and prostate cancer. Screening for prostate cancer can be considered using the prostate-specific antigen (PSA) test alone, or in conjunction with a digital rectal exam (in which the clinician uses a finger through the rectum to feel for prostate growths)—guidelines vary. Per the Canadian Urological Association in 2022, the recommended age to consider starting for prostate cancer screening is around 50 years of age for those who are at average risk. However, it is recommended that those at higher risk, including African, Caribbean, and Black (ACB) men, consider screening for prostate cancer earlier at age 45.

This new factsheet reviewed by Dr. Jordan Goodridge and Devan Nambiar is for frontline, healthcare and community workers serving queer and transmasculine guys. Racial and social determinants of health impact 2SGBTQ+ and transmasculine individuals’ access to HIV PrEP, testing & treatment, and STBBI screening.This document looks at multiple barriers to accessing care including: insurance, cost, […]